Sarilibo, Elena .
HRN: 27-98-68 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2025
AMPICILLIN 1GM (VIAL)
10/29/2025
11/05/2025
IV
2g
Q6hrs
PROM
Checking Final Appropriateness
10/29/2025
CEFAZOLIN 1GM (VIAL)
10/29/2025
10/29/2025
IV
2 G
Loading Dose
For CS
Checking Final Appropriateness
10/29/2025
CEFAZOLIN 1GM (VIAL)
10/29/2025
10/31/2025
IV
1g
Q6 X 4 Doses
S/p Cs
Checking Final Appropriateness
10/29/2025
CEFUROXIME 500MG (TAB)
10/29/2025
11/05/2025
PO
500mg
1 Tab BID X 7 Days
S/p Cs
Checking Final Appropriateness
10/29/2025
MUPIROCIN 2%, 15G (TUBE)
10/29/2025
11/05/2025
TOPICAL
Pea Size
Bid X 7 Days
S/p Cs
Checking Final Appropriateness
10/29/2025
CEFAZOLIN 1GM (VIAL)
10/29/2025
10/31/2025
IV
2 G
Q6× 4doses
Sp 1 LTCS
Checking Final Appropriateness